Aclipse Therapeutics
PrivateLast Round
Grant
Apr 20, 2022
Total Funding Raised
$4.4M
Company Overview
Aclipse Therapeutics is a biopharmaceutical company that develops novel and differentiated drugs to treat diseases with significant unmet medical needs, focusing on neuromuscular and gastrointestinal disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aclipse Therapeutics Comparables
Compare Aclipse Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CinDome Pharma | 81% | |
| Collaborative Medicinal Development | 81% | |
| Processa Pharmaceuticals | 78% | |
Aclipse Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 20, 2022 | ||||
| Grant | Jan 26, 2021 | ||||
| Series A | Sep 30, 2020 | ||||
| Grant | Sep 29, 2020 |
Key People
Founding team and executive leadership
Aclipse Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FightMND | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Medical Research Council | Grant |
| Gordian Life Sciences | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 52% MoM.
- Mar 25, 2025
Monthly visitors increased 40% MoM.
Aclipse Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aclipse Therapeutics's valuation, stock price, and market status.